Royalty Pharma to Announce Third Quarter 2024 Financial Results on November 6, 2024
Royalty Pharma plc (Nasdaq: RPRX) has announced its plans to release its third quarter 2024 financial results on Wednesday, November 6, 2024, before the U.S. financial markets open. The company will also host a conference call and simultaneous webcast at 8:30 a.m. Eastern Time on the same day.
Investors and interested parties can access the conference call information and view the live webcast by visiting the 'Investors' page on Royalty Pharma's official website. For those unable to attend the live event, a replay of the conference call and webcast will be archived on the company's website for at least 30 days, ensuring accessibility to the financial update.
Royalty Pharma plc (Nasdaq: RPRX) ha annunciato i suoi piani per rilasciare i risultati finanziari del terzo trimestre 2024 il mercoledì 6 novembre 2024, prima dell'apertura dei mercati finanziari statunitensi. L'azienda ospiterà anche una conferenza telefonica e un webcast simultaneo alle 8:30 ora della Costa Est nello stesso giorno.
Investitori e parti interessate possono accedere alle informazioni sulla conferenza telefonica e visualizzare il webcast dal vivo visitando la pagina 'Investitori' sul sito ufficiale di Royalty Pharma. Per coloro che non possono partecipare all'evento dal vivo, una registrazione della conferenza e del webcast verrà archiviata sul sito dell'azienda per almeno 30 giorni, garantendo accessibilità all'aggiornamento finanziario.
Royalty Pharma plc (Nasdaq: RPRX) ha anunciado sus planes para publicar sus resultados financieros del tercer trimestre de 2024 el miércoles 6 de noviembre de 2024, antes de la apertura de los mercados financieros en EE. UU. La compañía también llevará a cabo una llamada de conferencia y una transmisión simultánea por webcast a las 8:30 a.m. hora del Este ese mismo día.
Los inversores y partes interesadas pueden acceder a la información de la llamada de conferencia y ver la transmisión en vivo visitando la página 'Inversores' en el sitio web oficial de Royalty Pharma. Para quienes no puedan asistir al evento en vivo, se archivarà un repetición de la llamada de conferencia y del webcast en el sitio web de la empresa durante al menos 30 días, asegurando el acceso a la actualización financiera.
Royalty Pharma plc (Nasdaq: RPRX)는 2024년 3분기 재무 결과를 2024년 11월 6일 수요일에 미 주식 시장이 열리기 전에 발표할 계획이라고 발표했습니다. 회사는 같은 날 동부 표준시 오전 8시 30분에 전화 회의 및 동시 웨비나를 개최할 것입니다.
투자자와 관심 있는 당사자는 Royalty Pharma 공식 웹사이트에서 '투자자' 페이지를 방문하여 전화 회의 정보에 접근하고 실시간 웨비나를 시청할 수 있습니다. 실시간 이벤트에 참석할 수 없는 경우, 회의 및 웨비나의 재생이 회사 웹사이트에 최소 30일 동안 아카이브될 것입니다, 재무 업데이트에 대한 접근성을 보장합니다.
Royalty Pharma plc (Nasdaq: RPRX) a annoncé ses plans pour publier ses résultats financiers du troisième trimestre 2024 le mercredi 6 novembre 2024, avant l'ouverture des marchés financiers américains. L'entreprise organisera également une conférence téléphonique et un webcast simultané à 8h30, heure de l'Est le même jour.
Les investisseurs et parties intéressées peuvent accéder aux informations de la conférence téléphonique et visionner le webcast en direct en visitant la page 'Investisseurs' sur le site officiel de Royalty Pharma. Pour ceux qui ne peuvent pas assister à l'événement en direct, un replay de la conférence téléphonique et du webcast sera archivé sur le site de l'entreprise pendant au moins 30 jours, assurant ainsi l'accès à la mise à jour financière.
Royalty Pharma plc (Nasdaq: RPRX) hat seine Pläne bekannt gegeben, die finanziellen Ergebnisse für das dritte Quartal 2024 am Mittwoch, den 6. November 2024 vor der Öffnung der US-Finanzmärkte zu veröffentlichen. Das Unternehmen wird auch eine Telefonkonferenz und ein gleichzeitiges Webcast am 8:30 Uhr Eastern Time am selben Tag veranstalten.
Investoren und Interessierte können die Informationen zur Telefonkonferenz abrufen und das Live-Webcast besuchen, indem sie die 'Investoren'-Seite auf der offiziellen Website von Royalty Pharma besuchen. Für diejenigen, die an der Live-Veranstaltung nicht teilnehmen können, wird eine Wiederholung der Telefonkonferenz und des Webcasts mindestens 30 Tage lang auf der Unternehmenswebsite archiviert, um den Zugang zu den finanziellen Neuigkeiten zu gewährleisten.
- None.
- None.
NEW YORK, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will report its third quarter 2024 financial results on Wednesday, November 6, 2024 before the U.S. financial markets open. The company will host a conference call and simultaneous webcast at 8:30 a.m. Eastern Time that day.
Conference Call Information
Please visit the “Investors” page of the company’s website at https://www.royaltypharma.com/investors/events/ to obtain conference call information and to view the live webcast. A replay of the conference call and webcast will be archived on the company's website for at least 30 days.
About Royalty Pharma
Founded in 1996, Royalty Pharma is the largest buyer of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical industry, collaborating with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to leading global pharmaceutical companies. Royalty Pharma has assembled a portfolio of royalties which entitles it to payments based directly on the top-line sales of many of the industry’s leading therapies. Royalty Pharma funds innovation in the biopharmaceutical industry both directly and indirectly – directly when it partners with companies to co-fund late-stage clinical trials and new product launches in exchange for future royalties, and indirectly when it acquires existing royalties from the original innovators. Royalty Pharma’s current portfolio includes royalties on more than 35 commercial products, including Vertex’s Trikafta, GSK’s Trelegy, Roche’s Evrysdi, Johnson & Johnson’s Tremfya, Biogen’s Tysabri and Spinraza, AbbVie and Johnson & Johnson’s Imbruvica, Astellas and Pfizer’s Xtandi, Novartis’ Promacta, Pfizer’s Nurtec ODT and Gilead’s Trodelvy, and 16 development-stage product candidates. For more information, visit www.royaltypharma.com.
Royalty Pharma Investor Relations and Communications
+1 (212) 883-6637
ir@royaltypharma.com
FAQ
When will Royalty Pharma (RPRX) release its Q3 2024 financial results?
What time is Royalty Pharma's (RPRX) Q3 2024 earnings conference call?
Where can I find information about Royalty Pharma's (RPRX) Q3 2024 earnings call?
How long will the replay of Royalty Pharma's (RPRX) Q3 2024 earnings call be available?
